Cargando…
GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial
This study is aimed at comparing clinical pregnancy rates (CPRs) in patients who are administered either gonadotropin-releasing hormone agonist (GnRHa) or human chorionic gonadotropin (hCG) for ovulation trigger in intrauterine insemination (IUI) cycles. A prospective randomized comparative study wa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436329/ https://www.ncbi.nlm.nih.gov/pubmed/31001335 http://dx.doi.org/10.1155/2019/2487067 |
_version_ | 1783406797660356608 |
---|---|
author | Le, Minh Tam Nguyen, Dac Nguyen Zolton, Jessica Nguyen, Vu Quoc Huy Truong, Quang Vinh Cao, Ngoc Thanh Decherney, Alan Hill, Micah J. |
author_facet | Le, Minh Tam Nguyen, Dac Nguyen Zolton, Jessica Nguyen, Vu Quoc Huy Truong, Quang Vinh Cao, Ngoc Thanh Decherney, Alan Hill, Micah J. |
author_sort | Le, Minh Tam |
collection | PubMed |
description | This study is aimed at comparing clinical pregnancy rates (CPRs) in patients who are administered either gonadotropin-releasing hormone agonist (GnRHa) or human chorionic gonadotropin (hCG) for ovulation trigger in intrauterine insemination (IUI) cycles. A prospective randomized comparative study was conducted at Hue University Hospital in Vietnam. A total of 197 infertile women were randomly assigned to receive either GnRHa trigger (n = 98 cycles) or hCG trigger (n = 99 cycles) for ovulation trigger. Patients returned for ultrasound monitoring 24 hours after IUI to confirm ovulation. A clinical pregnancy was defined as the presence of gestational sac with fetal cardiac activity. There was no difference in ovulation rates in either group receiving GnRHa or hCG trigger for ovulation. Biochemical and CPR were higher in patients who received hCG (28.3% and 23.2%) versus GnRHa (14.3% and 13.3%) (p = 0.023, OR 0.42, 95%CI = 0.21 − 0.86 and p = 0.096, OR 0.51, 95%CI = 0.24 − 1.07, respectively). After adjusting for body mass index (BMI) and infertility duration, there was no difference in CPR between the two groups (OR 0.58, 95% CI 0.27-1.25, p = 0.163). In conclusion, the use of the GnRHa to trigger ovulation in patients undergoing ovulation induction may be considered in patients treated with IUI. |
format | Online Article Text |
id | pubmed-6436329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-64363292019-04-18 GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial Le, Minh Tam Nguyen, Dac Nguyen Zolton, Jessica Nguyen, Vu Quoc Huy Truong, Quang Vinh Cao, Ngoc Thanh Decherney, Alan Hill, Micah J. Int J Endocrinol Clinical Study This study is aimed at comparing clinical pregnancy rates (CPRs) in patients who are administered either gonadotropin-releasing hormone agonist (GnRHa) or human chorionic gonadotropin (hCG) for ovulation trigger in intrauterine insemination (IUI) cycles. A prospective randomized comparative study was conducted at Hue University Hospital in Vietnam. A total of 197 infertile women were randomly assigned to receive either GnRHa trigger (n = 98 cycles) or hCG trigger (n = 99 cycles) for ovulation trigger. Patients returned for ultrasound monitoring 24 hours after IUI to confirm ovulation. A clinical pregnancy was defined as the presence of gestational sac with fetal cardiac activity. There was no difference in ovulation rates in either group receiving GnRHa or hCG trigger for ovulation. Biochemical and CPR were higher in patients who received hCG (28.3% and 23.2%) versus GnRHa (14.3% and 13.3%) (p = 0.023, OR 0.42, 95%CI = 0.21 − 0.86 and p = 0.096, OR 0.51, 95%CI = 0.24 − 1.07, respectively). After adjusting for body mass index (BMI) and infertility duration, there was no difference in CPR between the two groups (OR 0.58, 95% CI 0.27-1.25, p = 0.163). In conclusion, the use of the GnRHa to trigger ovulation in patients undergoing ovulation induction may be considered in patients treated with IUI. Hindawi 2019-03-13 /pmc/articles/PMC6436329/ /pubmed/31001335 http://dx.doi.org/10.1155/2019/2487067 Text en Copyright © 2019 Minh Tam Le et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Le, Minh Tam Nguyen, Dac Nguyen Zolton, Jessica Nguyen, Vu Quoc Huy Truong, Quang Vinh Cao, Ngoc Thanh Decherney, Alan Hill, Micah J. GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial |
title | GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial |
title_full | GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial |
title_fullStr | GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial |
title_full_unstemmed | GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial |
title_short | GnRH Agonist versus hCG Trigger in Ovulation Induction with Intrauterine Insemination: A Randomized Controlled Trial |
title_sort | gnrh agonist versus hcg trigger in ovulation induction with intrauterine insemination: a randomized controlled trial |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436329/ https://www.ncbi.nlm.nih.gov/pubmed/31001335 http://dx.doi.org/10.1155/2019/2487067 |
work_keys_str_mv | AT leminhtam gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial AT nguyendacnguyen gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial AT zoltonjessica gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial AT nguyenvuquochuy gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial AT truongquangvinh gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial AT caongocthanh gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial AT decherneyalan gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial AT hillmicahj gnrhagonistversushcgtriggerinovulationinductionwithintrauterineinseminationarandomizedcontrolledtrial |